https://www.businesswire.com/news/home/20230522005093/en/Karuna-Therapeutics-to-Present-Data-from-the-EMERGENT-Program-Evaluating-KarXT-in-Schizophrenia-at-the-American-Society-of-Clinical-Psychopharmacology-Annual-Meeting
Karuna Therapeutics to Present Data from the EMERGENT Program Evaluating KarXT in Schizophrenia at...
Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living ...